Pandey utilized MolProphet platform to generate novel small molecules targeting aurora kinase A (AURKA) which is overexpressed in diverse types of cancer and acts as a synthetic lethal partner of several tumor suppressor genes [83–85]. The gene discussed is AURKA; the disease is cancer.